Explore more Articles in

BioTech

Novartis Gets Swiss Approval For First Malaria Drug For Babies – Novartis (NYSE:NVS)

Swissmedic, the Swiss Agency for Therapeutic Products, approved Novartis AG’s NVS Coartem (artemether-lumefantrine) Baby on Tuesday. This marks the first malaria medicine specifically approved...

Asian Markets Defy Tariff Woes While European Indices Gain on Trade Hopes

Despite US President Trump issuing 14 new tariff letters on Monday, 7 July, Asian stock markets defied expectations. Unlike the sharp sell-off following the...

DAX 40 Remains Steady as Markets Speculate EU’s Status in Ongoing US Tariff Talk

muted with trade developments in focus. rises on weakness.DAX Muted With Trade Developments in FocusThe EU was absent from Trump’s latest...

US Dollar May Weaken Due to Tariffs, Debt, and Economic Data

Although last week’s US (Non-Farm Payrolls) data beat expectations and gave a slight boost, the rise was not strong enough to change...
BioTech

Amylyx Eyes $2B Opportunity In Post-Surgery Sugar Crash Market – Amylyx Pharmaceuticals (NASDAQ:AMLX)

Guggenheim Partners on Monday initiated coverage on Amylyx Pharmaceuticals, Inc. AMLX, noting the company is poised to open post-bariatric hypoglycemia’s (PBH) blockbuster potential.PBH is...
BioTech

Nuvalent Touts ‘Positive’ Data From Lung Cancer Drug Trial – Nuvalent (NASDAQ:NUVL)

Nuvalent, Inc. NUVL on Tuesday announced in a press release pivotal data for zidesamtinib, a novel ROS1-selective inhibitor, in TKI (tyrosine kinase inhibitor) pre-treated patients...
BioTech

Why InMed’s Alzheimer’s Drug Candidate Is Fueling Sudden Stock Surge – InMed Pharmaceuticals (NASDAQ:INM)

InMed Pharmaceuticals Inc. INM stock is surging early Tuesday, with a session volume of 6.63 million compared to the average volume of 1.31 million,...
BioTech

Novo’s Wegovy Launch Heats Up Weight-Loss Battle With Eli Lilly – Novo Nordisk (NYSE:NVO)

Novo Nordisk A/S NVO has reportedly launched its weight-loss drug Wegovy (semaglutide) in India to compete with Eli Lilly And Co. LLY.In March this...
BioTech

Nektar Therapeutics Shares Double On Promising Eczema Drug Data – Nektar Therapeutics (NASDAQ:NKTR)

Nektar Therapeutics Inc NKTR stock is surging on Tuesday, with a session volume of 4.7 million compared to an average volume 239.7K as per...
BioTech

FDA Approves AstraZeneca And Daiichi Sankyo’s Datroway For EGFR-Mutated Lung Cancer – AstraZeneca (NASDAQ:AZN)

The Food and Drug Administration (FDA) on Monday approved AstraZeneca Plc’s AZN Datroway (datopotamab deruxtecan or Dato-DXd) for adult patients with locally advanced or...
1...101112...18Page 11 of 18

- A word from our sponsors -

Most Popular

Disclaimer: The content provided is for informational purposes only. We aim to keep the content current and accurate by updating it frequently. Sometimes the actual data can differ from what's stated on our website. Buttonwoodnews.com is an independent platform. While we are independent, we may be compensated for advertisements, sponsored products, or when you click on a link on our website. The contributors and authors are not registered or certified financial advisors. You should consult a financial professional before making any financial decisions.

Copyright © Button Wood News.